drugset / Trial / NCT00010361

Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders

NCT00010361

Completed 20 enrolled Fred Hutchinson Cancer Center
Treatment

Summary

OBJECTIVES: I. Determine the safety of total body irradiation and fludarabine followed by allogeneic peripheral blood stem cell or bone marrow transplantation in combination with cyclosporine and mycophenolate mofetil for establishing mixed chimerism in patients with inherited disorders. II. Determine whether this regimen can establish mixed chimerism in these patients. III. Determine whether mixed chimerism is sufficient to reverse disease symptoms in these patients. IV. Determine the safety of donor lymphocyte infusions to eliminate persistent disease in these patients with mixed chimerism.

Timeline

Start
2000-11
Primary completion
2007-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Cyclosporine Peptide Oral
Background Fludarabine Small molecule Intravenous
Background Mycophenolate Mofetil Small molecule Oral